AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE
Publication
, Journal Article
Desjardins, A; Herndon, J; McSherry, F; Ravelo, A; Lipp, E; Healy, P; Boulton, S; Peters, K; Vlahovic, G; Sampson, J; Friedman, A; Friedman, H
Published in: Neuro-Oncology
November 1, 2014
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v12 / v12
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Herndon, J., McSherry, F., Ravelo, A., Lipp, E., Healy, P., … Friedman, H. (2014). AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE. Neuro-Oncology, 16(suppl 5), v12–v12. https://doi.org/10.1093/neuonc/nou237.19
Desjardins, A., J. Herndon, F. McSherry, A. Ravelo, E. Lipp, P. Healy, S. Boulton, et al. “AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v12–v12. https://doi.org/10.1093/neuonc/nou237.19.
Desjardins A, Herndon J, McSherry F, Ravelo A, Lipp E, Healy P, et al. AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v12–v12.
Desjardins, A., et al. “AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v12–v12. Crossref, doi:10.1093/neuonc/nou237.19.
Desjardins A, Herndon J, McSherry F, Ravelo A, Lipp E, Healy P, Boulton S, Peters K, Vlahovic G, Sampson J, Friedman A, Friedman H. AT-19 * SINGLE INSTITUTION RETROSPECTIVE COMPARISON OF GLIOBLASTOMA (GBM) PATIENTS (PTS) INITIATED ON BEVACIZUMAB (BEV) BEFORE VERSUS AFTER RECURRENCE IN CLINICAL PRACTICE. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v12–v12.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2014
Volume
16
Issue
suppl 5
Start / End Page
v12 / v12
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences